Neos Therapeutics Statement: COVID-19 Update
DALLAS and FORT WORTH, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Jerry McLaughlin, President and CEO, made the following statement:We […]
Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing […]
Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
Soticlestat continues to appear to be safe and well-tolerated; the majority of the 11 patients showed a reduction in seizuresAll […]
Capital City Bank Group, Inc. Announces Change to Virtual Format for Annual Meeting of Shareowners to Be Held April 23, 2020
TALLAHASSEE, Fla., March 30, 2020 (GLOBE NEWSWIRE) — Capital City Bank Group (NASDAQ: CCBG) announced today that, due to the […]
Daré Bioscience Reports 2019 Financial Results and Provides a Company Update
SAN DIEGO, March 30, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported […]
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]
I-Mab Enters into Strategic Regional Partnership with Kalbe Genexine Biologics for Commercialization Rights of CD73 Antibody, TJD5, for Immuno-Oncology
– Kalbe Genexine Biologics (“KG Bio”) will receive right of first negotiation for an exclusive license to potentially commercialize I-Mab’s […]
Chuy’s Holdings, Inc. Provides COVID-19 Update
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today provided a business update in light of […]
Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations
Hunter Smith, Chief Financial Officer, appointed Interim Chief Executive Officer following completion of NDA submission to FDA Precautionary measures in place […]
BeyondSpring Initiates New Drug Application Rolling Submission for Plinabulin in China for Chemotherapy-Induced Neutropenia
– Potential to be First Superior Therapy to Standard of Care for Chemotherapy-Induced Neutropenia in 30 Years –– Targeting CIN […]
